Cart
sales@molnova.com
N-Formyl-Met-Leu-Phe-Lys
CAS No. 67247-11-4
N-Formyl-Met-Leu-Phe-Lys( fMLFK )
Catalog No. M22300 CAS No. 67247-11-4
N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 102 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 245 | In Stock |
|
| 50MG | 339 | In Stock |
|
| 100MG | 457 | In Stock |
|
| 200MG | 616 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Formyl-Met-Leu-Phe-Lys
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.
-
DescriptionN-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.Chemotactic peptide (fMLFK) binds specifically to receptors on leukocyte membranes. Uptake of chemotactic peptides can contribute to quantitative assessment of neutrophils in localized inflammatory processes and is independent of associated edema formation or microcirculatory compromise.
-
In Vitro——
-
In Vivo——
-
SynonymsfMLFK
-
PathwayOthers
-
TargetOther Targets
-
RecptorFPR1|FPR2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67247-11-4
-
Formula Weight565.73
-
Molecular FormulaC27H43N5O6S
-
Purity>98% (HPLC)
-
SolubilityH2O
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Iopamidol
Iopamidol is a nonionic, low-osmolar iodinated contrast agent.
-
Eliglustat hemitartr...
Eliglustat Hemitartrate, with an IC50 of 24 nM, is a specific, potent, oral active glucocerebral glycosidase inhibitor.Eliglustat tartrate shows good potency with an IC50 of 24 nM and specificity against the target enzyme.A novel inhibitor of glucosylceramide synthase (Genz-112638) and assessed its activity in a murine model of Gaucher disease (D409V/null).?Biochemical characterization of Genz-112638 showed good potency (IC(50) approximately 24nM) and specificity against the target enzyme.?
-
Suberosin
Suberosin exhibits anti-inflammatory and anticoagulant activities it also shows biting deterrent activity against Aedes aegypti it may be useful for use as mosquito larvicidal agent.
